Equities

Lifecore Biomedical Inc

Lifecore Biomedical Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.62
  • Today's Change0.42 / 8.08%
  • Shares traded235.48k
  • 1 Year change-31.80%
  • Beta0.9322
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of May 26 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue128103111
OPERATING EXPENSES
Cost of revenue total867572
Selling, general and admin. expenses, total403935
Depreciation/amortization------
Unusual expense(income)1.66268.36
Other operating expenses, total------
Total operating expense137149123
Operating income(8.84)(46)(12)
Other, net36(0.81)6.57
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes9.51(64)(21)
Provision for income taxes0.180.31(5.21)
Net income after taxes9.33(64)(15)
Minority interest------
Net income before extra. Items9.33(64)(15)
Total extraordinary items2.68(35)(101)
Net income12(100)(117)
Inc.avail. to common excl. extra. Items9.33(64)(15)
Inc.avail. to common incl. extra. Items12(100)(117)
EPS RECONCILIATION
Basic/primary weighted average shares303029
Basic/primary eps excl. extra items0.31(2.14)(0.53)
Basic/primary eps incl. extra items0.39(3.32)(3.96)
Dilution adjustment------
Diluted weighted average shares373029
Diluted eps excl. extra items0.25(2.14)(0.53)
Diluted eps incl. extra items0.33(3.32)(3.96)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.371816
SUPPLEMENTAL INCOME
Depreciation, supplemental8.861318
Total special items1347102
NORMALISED INCOME
Normalized income before taxes23(17)82
Effect of special items on income taxes0.251636
Income tax excluding impact of special items0.441731
Normalized income after tax22(34)51
Normalized income avail. to common22(34)51
Basic normalized EPS0.73(1.13)1.73
Diluted normalized EPS0.61(1.13)1.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.